Cynthia Bowman-Stroud, MD
Internal Medicine · Paducah, KYNPI 1912045527
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,524 of the $6,656 with a category attached, or 68.0%. 32 manufacturers reported payments, led by Novo Nordisk AS at 46.2% of the total. Reporting peaked in 2019 at $3,933 and has fallen 96.9% since, to $121 in 2025. Among internal medicine clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $34.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$3K
- AbbVie$458
- Ironshore Pharmaceuticals Inc.$398
- Novo Nordisk$366
- Amgen$355
- Lilly USA, LLC$313
- plus $2K from 26 others
Across 435 payments — averaging $521.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$177K
- Avanir Pharmaceuticals, Inc.$18K
- Janssen Research & Development, LLC$17K
- AstraZeneca$8K
- Genentech, Inc.$5K
- Esperion Therapeutics, Inc.$2K
- plus $1K from 1 others
What the payments were for
- Travel & lodging$2,08731%
- Food & beverage$4,52468%
- Education$461%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 8 | $3,074 |
| AbbVie(2 entities) | 27 | $458 |
| Ironshore Pharmaceuticals Inc. | 9 | $398 |
| Novo Nordisk | 24 | $366 |
| Amgen | 24 | $355 |
| Lilly USA, LLC | 19 | $313 |
| AstraZeneca | 6 | $225 |
| Idorsia Pharmaceuticals US Inc | 8 | $173 |
| Tris Pharma Inc | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 2 | $122 |
| Novartis | 8 | $122 |
| Amarin Pharma, Inc. | 7 | $110 |
| Corium, LLC | 6 | $101 |
| Sanofi-aventis U.S. LLC | 7 | $98 |
| Boehringer Ingelheim | 4 | $81 |
| Pfizer | 5 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Johnson & Johnson | 3 | $44 |
| Shire North American Group Inc | 3 | $42 |
| Lundbeck LLC | 2 | $41 |
| Eisai Inc. | 3 | $39 |
| Exact Sciences | 2 | $35 |
| Merck | 2 | $23 |
| Bausch Health US, LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $17 |
| GSK | 1 | $17 |
| Si-bone, Inc. | 1 | $15 |
| Bayer | 1 | $13 |
| Abbott | 1 | $12 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$125
- Quillivant$125
- Quillichew ER$125
- AIRSUPRA$123
- QUVIVIQ$104
- QELBREE$104
How this compares
$6,656 in reported general payments places this provider in the 90th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 60 | $50,180 |
| EliquisApixaban | 18 | $29,077 |
| XareltoRivaroxaban | 25 | $21,807 |
| JanuviaSitagliptin Phosphate | 18 | $21,748 |
| OzempicSemaglutide | 20 | $21,040 |
| MounjaroTirzepatide | 20 | $18,753 |
| CreonLipase/Protease/Amylase | 12 | $11,662 |
| Bydureon BciseExenatide Microspheres | 11 | $8,953 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $8,094 |
| FarxigaDapagliflozin Propanediol | 12 | $8,019 |
| Repatha SureclickEvolocumab | 12 | $7,122 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $5,912 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $3,073 |
| SynthroidLevothyroxine Sodium | 23 | $2,694 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,894 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $81 | $50,18060 claims |
| PfizerEliquis | $72 | $29,07718 claims |
| Johnson & JohnsonXarelto | $44 | $21,80725 claims |
| MerckJanuvia | $23 | $21,74818 claims |
| Novo NordiskOzempic | $366 | $21,04020 claims |
| Lilly USA, LLCMounjaro | $313 | $18,75320 claims |
| AbbVieCreon, Synthroid | $458 | $14,35635 claims |
| AstraZenecaFarxiga | $225 | $8,01912 claims |
| Sanofi-aventis U.S. LLCLantus | $98 | $1,21620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Paducah
- Christopher PhillipsPaducah$16K
- Fares KhaterWhitesburg$412K
- Bernard BuchananOwensboro$185K
- David ManninoLexington$168K
- John PeppinCynthiana$108K
- Sanjay KaulBrownsville$69K
- John JonesHazard$63K
- Robert SasserLouisville$62K
- Justin LandeDanville$60K
- Sanjiv GuptaGrayson$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.